Home › NDC Lookup › Ingredients › Sevelamer Carbonate › 70771-1520-04
Sevelamer carbonate 800 mg Tablet, Film Coated — NDC 70771-1520-04 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Sevelamer carbonate 800 mg Tablet, Film Coated — NDC 70771-1520-4 (Billing 70771-1520-04)

by Zydus Lifesciences Limited · 10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK

This is a package of Sevelamer carbonate 800 mg Tablet, Film Coated from Zydus Lifesciences Limited, marketed since Sep 2020 and currently FDA-listed.

NDC 70771-1520-04
🏷️ FDA NDC (as labeled) 70771-1520-4 billing pads the package segment with a zero
This package
Contains10 tablet, film coated in 1 blister pack Pack sizes3 compare ↓
Also priced by: Part D plans $0.3584/unit — full pricing hub ↓
Product page 70771-1520-00 Also comes in: 270 tablets 70771-1520-8 1000 tablets 70771-1520-0
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 70771-1520-4 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
70771 labeler · 1520 product · 4 package
Package marketed since
Sep 17, 2020
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC)
0368382824271
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70771-1520-4
Product NDC 70771-1520
11-digit billing NDC 70771152004
RxCUI 749206
UNII 9YCX42I8IU
UPC 0368382824271
Application # ANDA207759
SPL Set ID cbdee883-ccc7-4c55-965d-b608a214b375
Established class (EPC) Phosphate Binder
Mechanism of action Phosphate Chelating Activity
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-09-17
Route ORAL
Dosage form TABLET, FILM COATED
Substance SEVELAMER CARBONATE
TE code (Orange Book) AB · RLD · RS
Quick answers
  • RxCUI (RxNorm): 749206
Why two NDCs? The FDA registers this code as 70771-1520-4 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70771-1520-04. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Phosphate Binder class.

Pharmacologic class Phosphate Binder
Drug family (ATC) Drugs for treatment of hyperkalemia and hyperphosphatemia
How it works Phosphate Chelating Activity
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It lowers high phosphorus in your blood if you have chronic kidney disease and are on dialysis. It does this by binding phosphate from food in your gut.
  • Take it by mouth with meals, usually three times a day. Your prescriber sets and adjusts the amount based on your blood tests. Follow your pharmacy label.
  • Stomach upset is most common, such as nausea, vomiting, diarrhea, gas, indigestion, and constipation. Call your doctor if constipation is severe or worsening, or if you have severe...
  • Yes. Ciprofloxacin and mycophenolate need to be spaced apart from sevelamer. Tell us if you take levothyroxine, cyclosporine or tacrolimus, since your doctor may separate timing or...
📖 Read our full Sevelamer guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.3584 $35.84 / 100 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70771-1520-00 70771-1520-0 Main listing 1000 TABLET, FILM COATED in 1 BOTTLE 2020-09-17 — Active
70771-1520-04 You're viewing this 10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK 2020-09-17 — Active
70771-1520-08 70771-1520-8 270 TABLET, FILM COATED in 1 BOTTLE 2020-09-17 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack.
What NDC number is used to bill for this package of Sevelamer carbonate 800 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Sevelamer Carbonate 800 mg 00904-6707-06 Major 1 tablet $0.214 AB Availability likely —
Sevelamer Carbonate 800 mg 11788-0116-07 AiPing 270 tablets $0.214 AB Availability likely —
Sevelamer Carbonate 800 mg 16714-0814-01 NorthStar 270 tablets $0.214 AB Availability likely —
Sevelamer Carbonate 800 mg 24979-0186-46 TWi 270 tablets $0.214 AB Availability likely —
Sevelamer Carbonate 800 mg 33342-0215-58 Macleods 270 tablets $0.214 AB Availability likely —
Sevelamer Carbonate 800 mg 50268-0720-15 AvPAK 1 tablet $0.214 AB Availability likely —
Sevelamer Carbonate 800 mg 55111-0789-11 DR. 4 tablets $0.214 AB Availability likely —
Sevelamer Carbonate 800 mg 60687-0328-31 American 1 tablet $0.214 AB Availability likely —
Sevelamer Carbonate 800 mg 68094-0034-64 Precision 10 tablets $0.214 AB Availability likely —
Sevelamer carbonate 800 mg 69097-0967-93 Cipla 270 tablets $0.214 AB Availability likely —
Sevelamer Carbonate 800 mg 69367-0423-27 Westminster 270 tablets $0.214 AB Availability likely —
Sevelamer carbonate 800 mg 76282-0407-27 Exelan 270 tablets $0.214 AB Availability likely —
Sevelamer carbonate 800 mg 76282-0664-27 Exelan 270 tablets $0.214 AB Availability likely —
Sevelamer Carbonate 800 mg 00955-1050-27 Sanofi-Aventis 270 tablets $0.254 — FDA listed —
Renvela 800 mg 58468-0133-01 Genzyme 270 tablets $5.685 — Availability likely —
Sevelamer Carbonate 800 mg 00615-8239-39 NCS 30 tablets — AB FDA listed —
Sevelamer Carbonate 800 mg 00955-1057-30 Sanofi-Aventis 270 tablets — — FDA listed —
Sevelamer Carbonate 800 mg 17856-0921-01 ATLANTIC 1 tablet — AB FDA listed —
Sevelamer Carbonate 800 mg 42571-0378-30 Micro 30 tablets — — Discontinued —
Sevelamer Carbonate 800 mg 51407-0706-27 Golden 270 tablets — AB FDA listed —
Sevelamer Carbonate 800 mg 55154-3358-00 Cardinal 1 tablet — AB FDA listed —
Sevelamer Carbonate 800 mg 55154-8188-00 Cardinal 1 tablet — AB FDA listed —
Sevelamer Carbonate 800 mg 58624-5001-02 Shandong 30 tablets — AB FDA listed —
Sevelamer Carbonate 800 mg 64380-0872-04 Strides 30 tablets — AB FDA listed —
Sevelamer Carbonate 800 mg 65162-0058-09 Amneal 90 tablets — AB FDA listed —
Sevelamer Carbonate 800 mg 65862-0921-18 Aurobindo 180 tablets — AB FDA listed —
Sevelamer carbonate 800 mg 68382-0824-10 Zydus 1000 tablets — AB FDA listed —
Sevelamer carbonate 800 mg 68475-0010-01 Navinta 30 tablets — AB FDA listed —
Sevelamer carbonate 800 mg 69097-0893-93 Cipla 270 tablets — AB FDA listed —
Sevelamer carbonate 800 mg 70710-2170-03 Zydus 30 tablets — AB FDA listed —
Sevelamer carbonate 800 mgthis 70771-1520-04 Zydus 10 tablets — AB FDA listed —
Sevelamer Carbonate 800 mg 71205-0966-67 Proficient 270 tablets — AB FDA listed —
Sevelamer Carbonate 800 mg 71335-3021-01 Bryant 50 tablets — AB Discontinued —
Sevelamer Carbonate 800 mg 72162-2499-01 Bryant 100 tablets — AB FDA listed —
Sevelamer Carbonate 800 mg 72789-0562-94 PD-Rx 270 tablets — AB FDA listed —
Sevelamer Carbonate 800 mg 73190-0014-27 AvKARE 270 tablets — AB FDA listed —
Sevelamer Carbonate 800 mg 85898-0101-27 Marp 270 tablets — — FDA listed —
Sevelamer Carbonate 800 mg 87367-0266-12 INSIGNAMEDEX 270 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Sep 2020
📍
2026
Currently FDA-listed
6 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeCapsule
Imprint824
Size2 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII D5340Y2I9G
    Castor oil is a natural plant-based oil used in medicines as a lubricant, laxative agent, and solvent. It helps medicine ingredients dissolve or flow smoothly and can aid bowel movement in formulations designed for that purpose.
  • UNII 68401960MK
    Crospovidone is a synthetic polymer made from polyvinylpyrrolidone. It acts as a disintegrant, helping tablets break apart quickly in the stomach so the medicine dissolves and absorbs into the body.
  • UNII 4W5IH7FLNY
    A clear, oily liquid derived from sebacic acid and butanol. It works as a plasticizer and solvent in pharmaceutical coatings and films, helping them stay flexible and smooth.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 36SFW2JZ0W
    Hypromellose 2910 is a plant-based thickening agent derived from cellulose. In medicines, it forms a protective coating on tablets or capsules and controls how quickly the drug dissolves and releases into your body.
  • UNII R75537T0T4
    Hypromellose 2910 is a plant-derived thickening agent made from cellulose. It serves as a binder that holds tablet ingredients together, a film-coating for pills, and a viscosity controller in liquids.
  • UNII 1IVH67816N
    Hypromellose 2910 is a plant-derived cellulose compound used as a thickener and film-former in medicines. It helps control how quickly the medication dissolves and creates protective coatings on tablets or capsules.
  • UNII 0WZ8WG20P6
    Hypromellose 2910 is a plant-based cellulose derivative that acts as a thickener, binder, and film-coating agent. It helps control how quickly the medicine dissolves and protects the tablet or capsule from moisture and light.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 532B59J990
    Polyvinyl alcohol is a synthetic polymer made from plant-derived materials. It's used as a binder to hold ingredients together, a film-former in coatings, and a thickener in liquid formulations.
  • UNII RDH86HJV5Z
    Povidone K90 is a synthetic polymer made from a chemical called vinyl pyrrolidone. It acts as a binder to hold pill ingredients together and as a dispersant to help the medicine break down and dissolve properly in your body.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 46N107B71O
    Shellac is a natural resin secreted by the lac beetle. It's used as a coating on tablets and capsules to control how quickly the medicine dissolves and to improve appearance and stability.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII XHX3C3X673
    Triacetin is a clear, oily liquid made from glycerin and acetic acid. It works as a plasticizer and solvent in medicines, helping soften coatings and improve how liquids mix together in formulations.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

18 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerZydus Lifesciences Limited
Application holderZYDUS PHARMACEUTICALS USA INC
FDA applicationANDA207759 (ANDA)
Labeler code70771
First marketedSep 2020
Product typeHuman Prescription Drug
Portfolio720 products on file

More NDCs from Zydus Lifesciences Limited labeler code 70771

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 Package Label / Principal Display Panel
📄 Package Label / Principal Display Panel 15 words ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1520-8 Sevelamer Tablets, 800 mg 270 Tablets Rx only label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Sevelamer Carbonate — the program that covers self-administered drugs. 10 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Sevelamer Carbonate. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$892.5K
Claims incl. refills
10.8K
Beneficiaries
6.3K
Spend / beneficiary
$141.12
Spend / claim
$82.77
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for SEVELAMER CARBONATE — the ingredient across all brands.

Top reported reactions

Constipation2,547
Diarrhoea1,045
Pruritus1,009
Nausea816
Chronic Kidney Disease676
End Stage Renal Disease672
Renal Failure664

Age at onset

Infant4
Child28
Adolescent10
Adult4,414
Elderly777

Reporter sex

11,427 reports
Male · 48%
Female · 44%
Unknown · 8%

Serious outcomes

Hospitalization3,028
Death1,217
Life-threatening236
Disabling157
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 790 133
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 270 tablets (70771-1520-08), 1000 tablets (70771-1520-00). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70771-1519-03 · Zydus 70771-1521-03 · Zydus →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.